Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.
Cellular Oncology (Dordrecht)
Viol, Fabrice F; Sipos, Bence B; Fahl, Martina M; Clauditz, Till S TS; Amin, Tania T; Kriegs, Malte M; Nieser, Maike M; Izbicki, Jakob R JR; Huber, Samuel S; Lohse, Ansgar W AW; Schrader, Jörg J
Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing.
Jnci Cancer Spectrum
Poulos, Rebecca C RC; Perera, Dilmi D; Packham, Deborah D; Shah, Anushi A; Janitz, Caroline C; Pimanda, John E JE; Hawkins, Nicholas N; Ward, Robyn L RL; Hesson, Luke B LB; Wong, Jason W H JWH
Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.
Plos One
Stafford, Jaime L JL; Dyson, Gregory G; Levin, Nancy K NK; Chaudhry, Sophia S; Rosati, Rita R; Kalpage, Hasini H; Wernette, Courtney C; Petrucelli, Nancie N; Simon, Michael S MS; Tainsky, Michael A MA
Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Maxwell, Jill A JA; Johnson, Stewart P SP; McLendon, Roger E RE; Lister, David W DW; Horne, Krystle S KS; Rasheed, Ahmed A; Quinn, Jennifer A JA; Ali-Osman, Francis F; Friedman, Allan H AH; Modrich, Paul L PL; Bigner, Darell D DD; Friedman, Henry S HS